Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Corvus Pharmaceuticals (NASDAQ: CRVS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 13-16, 2025. Richard A. Miller, M.D., the company's president and chief executive officer, will engage in one-on-one investor meetings and deliver a corporate overview presentation.
The presentation is scheduled for Wednesday, January 15, 2025, at 2:15 pm ET / 11:15 am PT. An audio webcast will be available live and accessible for 30 days after the event through the investor relations section of Corvus's website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CRVS declined 1.74%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
BURLINGAME, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, will conduct one-on-one meetings with investors and present a corporate overview at the 43rd Annual J.P. Morgan Healthcare Conference, which is being held in San Francisco from January 13-16, 2025. The Company’s presentation will be on Wednesday, January 15 at 2:15 pm ET / 11:15 am PT.
An audio webcast of the presentation will be available live and for 30 days following the event. The webcast may be accessed via the investor relations section of the Corvus website.
About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com.
INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com
MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
+1-949-903-4750
sseapy@realchemistry.com
FAQ
When is Corvus Pharmaceuticals (CRVS) presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will the CRVS J.P. Morgan Conference presentation webcast be available?
What type of meetings will CRVS conduct at the J.P. Morgan Healthcare Conference 2025?
Where can investors access the CRVS J.P. Morgan Conference presentation webcast?
What are the dates for the 43rd J.P. Morgan Healthcare Conference where CRVS is presenting?
